Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio Essence (BIOE) EPS (Weighted Average and Diluted) (2021 - 2025)

Bio Essence has reported EPS (Weighted Average and Diluted) over the past 5 years, most recently at $0.02 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) changed N/A year-over-year to $0.02; the TTM value through Dec 2025 reached $0.01, up 125.0%, while the annual FY2025 figure was $0.02, 166.67% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.02 at Bio Essence, up from -$0.01 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.02 in Q4 2025 and troughed at -$0.03 in Q3 2024.
  • A 5-year average of -$0.0 and a median of $0.0 in 2021 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 301.04% in 2023 and later surged 199.38% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.0 in 2021, then surged by 135.16% to $0.01 in 2022, then plummeted by 254.88% to -$0.01 in 2023, then crashed by 200.0% to -$0.03 in 2024, then surged by 166.67% to $0.02 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for BIOE at $0.02 in Q4 2025, -$0.01 in Q1 2025, and -$0.03 in Q3 2024.